Items where authors include "Duncan, E.L."

Article

Cronin, O. orcid.org/0000-0002-1365-9942, Forsyth, L., Goodman, K. et al. (39 more authors) (2019) Zoledronate in the prevention of Paget's (ZiPP) : protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone. BMJ Open, 9 (9). e030689.

Barraza-García, J., Rivera-Pedroza, C.I., Hisado-Oliva, A. et al. (10 more authors) (2017) Broadening the phenotypic spectrum of POP1-skeletal dysplasias: identification of POP1 mutations in a mild and severe skeletal dysplasia. Clinical Genetics, 92 (1). ISSN 0009-9163

Gregson, C.L., Wheeler, L., Hardcastle, S.A. et al. (18 more authors) (2016) Mutations in known monogenic high bone mass loci only explain a small proportion of high bone mass cases. Journal of Bone and Mineral Research, 31 (3). pp. 640-649. ISSN 0884-0431

Estrada, K., Styrkarsdottir, U., Evangelou, E. et al. (178 more authors) (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature Genetics, 44 (5). pp. 491-501. ISSN 1061-4036

Gregson, C.L., Steel, S.A., O'Rourke, K.P. et al. (24 more authors) (2012) 'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporosis International, 23 (2). pp. 643-654. ISSN 0937-941X

Duncan, E.L., Danoy, P., Kemp, J.P. et al. (44 more authors) (2011) Genome-Wide Association Study Using Extreme Truncate Selection Identifies Novel Genes Affecting Bone Mineral Density and Fracture Risk. PLoS Genetics, 7 (4). e1001372. ISSN 1553-7390